Latest Reports
Heavy Menstrual Bleeding (HMB) Market
Heavy Menstrual Bleeding (HMB) Market, By Treatment Type (Medications, Surgical Interventions, Other Treatments), By Disease Type (Uterine Fibroids, Endometriosis, Adenomyosis, Hormonal Imbalances, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Device Type (Endometrial Ablation Devices, Hysteroscopes, Resectoscopes, Others), By Technology (Radiofrequency Ablation, Cryoablation, Thermal Balloon Ablation, Hydrothermal Ablation, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Bayer AG, Ferring Pharmaceuticals, Myovant Sciences, Allergan plc, Gedeon Richter Plc, Hologic, Inc.
Fibrocystic Breast Condition Market
Fibrocystic Breast Condition Market, By Treatment Type (Hormone Therapy, Pain Medication, Surgery, Lifestyle Modifications, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Gynecology Centers, Others), By Age Group (Below 30 Years, 30-39 Years, 40-49 Years, 50-59 Years, 60 Years and Above), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Genzyme Corporation, AstraZeneca, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Bayer AG
Premature Ejaculation Market
Premature Ejaculation Market, By Treatment Type (Behavioral Techniques, Topical Treatments, Oral Medications, Counseling and Therapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Others), By Age Group (Below 20 Years, 20-30 Years, 31-40 Years, 41-50 Years, above 50 Years), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Others), By Cause (Psychological Factors, Biological Factors, Lifestyle Factors, Medication-Induced, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Promescent, Ixcingo, Absorption Pharmaceuticals, Plethora Solutions, Allergan
Fallopian Tube Cancer Market
Fallopian Tube Cancer Market, By Treatment Type (Chemotherapy, Targeted Therapy, Hormone Therapy, Radiation Therapy Surgery), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Drug Type (Branded, Generics), By Molecule Type (Small Molecules, Biologics, Others), By Stage at Diagnosis (Early Stage (Stage I and II), Advanced Stage (Stage III and IV), Recurrent), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AstraZeneca, GlaxoSmithKline, Merck & Co., Roche, Pfizer, Novartis, Eli Lilly and Company
Epithelial Ovarian Cancer Market
Epithelial Ovarian Cancer Market, By Treatment Type (Chemotherapy, Targeted Therapy, Hormone Therapy, Surgery, Others), By Cancer Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Ovarian Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Clinics, Cancer Research Institutes, Others), By Stage (Early-Stage (Stage I, Stage II), Advanced Stage), By Molecule Type (Small Molecules, Biologics, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AstraZeneca, GlaxoSmithKline, Roche, Merck & Co., Pfizer, Johnson & Johnson, Novartis
Endometriosis Market
Endometriosis Market, By Treatment Type (Hormonal Therapy, Non-Hormonal Therapy, Surgical Treatment, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Gynecology Clinics, Fertility Centers, Research Institutes, Others), By Age Group (Below 30 Years, 30-45 Years, Above 45 Years), By Severity (Minimal, Mild, Moderate, Severe), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: AbbVie, Bayer AG, Pfizer, Myovant Sciences, ObsEva SA, Ferring Pharmaceuticals
Bacterial Vaginosis Market
Bacterial Vaginosis Market, By Treatment Type (Antibiotics, Probiotics, Prebiotics, Combination Therapy, Others), By Route of Administration (Oral, Vaginal, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By End-User (Hospitals, Specialty Clinics, Gynecology Centers, Others), By Dosage Form (Tablets, Capsules, Gels, Creams, Suppositories, Injections, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Lupin Pharmaceuticals, Symbiomix Therapeutics, Starpharma Holdings, Merck & Co., Pfizer Inc.
Anovulation Market
Anovulation Market, By Treatment Type (Medication, Assisted Reproductive Technology (ART), Surgical Intervention, Others), By Disease Indication (Polycystic Ovary Syndrome (PCOS), Hypothalamic Amenorrhea, Premature Ovarian Failure, Hyperprolactinemia, Thyroid Disorders, Others), By Route of Administration (Oral, Injectable, Implants, Others), By End-user (Hospitals, Fertility Clinics, Academic and Research Institutes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Age Group (Below 25 Years, 25-35 Years, 35-45 Years, above 45 Years), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Merck & Co., Inc., Ferring Pharmaceuticals, Bayer AG, Novartis AG, Pfizer Inc., Sanofi
Erectile Dysfunction Market
Erectile Dysfunction Market, By Product Type (Oral Medications, Injectable Medications, Penile Implants, Vacuum Devices, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Mail-order, Others), By Age Group (Below 30 Years, 30-50 Years, 51-70 Years, Above 70 Years), By Disease Indication (Diabetes, Cardiovascular Diseases, Neurological Disorders, Prostate Cancer, Others), By End User (Hospitals, Clinics, Home Care Settings, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Pfizer Inc., Eli Lilly and Company, Bayer AG, Allergan plc, Mylan N.V., Sanofi S.A.
Charcot-Marie-Tooth Disease Market
Charcot-Marie-Tooth Disease Market, By Type of Charcot-Marie-Tooth Disease (CMT1 (Demyelinating CMT), CMT2 (Axonal CMT), CMT3 (Dejerine-Sottas Disease), CMT4 (Demyelinating CMT with other inherited disorders), Others), By Mutation Type (PMP22 Duplication, MFN2 Mutation, GJB1 Mutation, MPZ Mutation, SH3TC2 Mutation, GDAP1 Mutation, Others), By Treatment Type (Gene Therapy, Symptomatic Treatment, Physiotherapy, Assistive Devices, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.Show More
- calendar_month Study Period: 2024-2031
- date_range Base Year: 2023
- apartment Key Players: Ionis Pharmaceuticals, Biogen, Pharnext, Acceleron Pharma, Alnylam Pharmaceuticals, Sanofi